Kantipur Pharmaceuticals Lab Gets SEBON Approval to Launch Rs 17 Crore IPO
Summary
Kantipur Pharmaceuticals Lab has received approval from the Securities Board of Nepal to launch a Rs 17 crore initial public offering. The company will issue 1.7 million shares, or 21.25 percent of its paid-up capital, with Muktinath Capital managing the offering.
Key Points
- Kantipur Pharmaceuticals Lab has secured SEBON approval to issue an IPO to the general public.
- The company will offer 1.7 million shares worth Rs 17 crore, equal to 21.25 percent of its paid-up capital.
- Muktinath Capital has been appointed as the issue and sales manager for the share issuance.
- The company operates an animal health business focused on veterinary medicines, animal nutrition products, and related health items.
